Published Online
on March 15, 2004

A more recent version of this article appeared on April 6, 2004

This Article Full Text (PDF) All Versions of this Article: 109/13/1660    most recent 01.CIR.0000124067.35915.E0v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wu, J. Articles by Li, J. Search for Related Content PubMed PubMed Citation Articles by Wu, J. Articles by Li, J. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Related Collections Apoptosis Ischemic biology - basic studies Valvular heart disease Other Vascular biology

Submitted on March 7, 2003
Revised on December 15, 2003
Accepted on December 30, 2003

PR39 Inhibits Apoptosis in Hypoxic Endothelial Cells. Role of Inhibitor Apoptosis Protein-2

Jiaping Wu MD, Cherie Parungo MD, Guifu Wu MD, PhD, Peter M. Kang MD, Roger J. Laham MD, Frank W. Sellke MD, Michael Simons MD, and Jian Li MD, PhD^*

From the Angiogenesis Research Center, Divisions of Cardiology (J.W., C.P., G.W., P.M.K., R.J.L., J.L.) and Cardiothoracic Surgery (F.W.S.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass, and Section of Cardiology, Dartmouth-Hitchcock Medical Center, Dartmouth Medical School, Hanover, NH (M.S.).

^* To whom correspondence should be addressed. E-mail: jli{at}bidmc.harvard.edu.

Background--PR39 is a proline- and arginine-rich peptide implicated in wound healing and myocardial ischemia protection. To determine the potential mechanisms of PR39 in ischemia, we examined the role of PR39 in hypoxia-induced apoptosis in vascular endothelial cells.

Methods and Results--Hypoxia results in an increase of apoptosis in bovine aortic endothelial cells (BAECs), as determined by terminal deoxynucleotidyl transferase-mediated dUTP biotin nick-end labeling (TUNEL) analysis and caspase-3 activity. Hypoxia induced 66.2±2.7% TUNEL-positive cells, whereas in the presence of synthesized PR39 peptide, TUNEL-positive cells were reduced to 29.6±1.9% (P<0.05). After 24 hours of hypoxia, the addition of PR39 reduced caspase-3 activity to 3.17±0.47 pMol/min from 10.52±0.55 pMol/min in hypoxic BAECs. Moreover, PR39 increased inhibitor of apoptosis protein-2 (IAP-2) gene and protein expression by 3-fold in a time- and dose-dependent manner. The induction of IAP-2 by PR39 conferred an increase in IAP-2 gene transcription and IAP-2 mRNA stability. Furthermore, inhibiting IAP-2 with second mitochondria-derived activator of caspase (Smac) and with small interfering RNA targeting IAP-2 abrogated the ability of PR39 to reduce caspase-3 activity.

Conclusions--We provide the first direct evidence for PR39 as an antiapoptotic factor in endothelial cells during hypoxia. These data suggest that PR39 inhibits hypoxia-induced apoptosis and decreases caspase-3 activity in endothelial cells through an increase of IAP-2 expression.

Key words: peptides • hypoxia • apoptosis • cells, endothelial

This article has been cited by other articles:

				E. W. Childs, B. Tharakan, N. Byrge, J. H. Tinsley, F. A. Hunter, and W. R. Smythe Angiopoietin-1 inhibits intrinsic apoptotic signaling and vascular hyperpermeability following hemorrhagic shock Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2285 - H2295. [Abstract] [Full Text] [PDF]

				M. J. Post, K. Sato, M. Murakami, J. Bao, D. Tirziu, J. D. Pearlman, and M. Simons Adenoviral PR39 improves blood flow and myocardial function in a pig model of chronic myocardial ischemia by enhancing collateral formation Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R494 - R500. [Abstract] [Full Text] [PDF]

				L. Tomasinsig, B. Skerlavaj, N. Papo, B. Giabbai, Y. Shai, and M. Zanetti Mechanistic and Functional Studies of the Interaction of a Proline-rich Antimicrobial Peptide with Mammalian Cells J. Biol. Chem., January 6, 2006; 281(1): 383 - 391. [Abstract] [Full Text] [PDF]